George Church

American geneticist

Follow George Church on Notably News to receive short updates to your email — rarely!

2022 Fierce Pharma featured Church among the most influential people in biopharma, highlighting his continued significance in the biotechnology and pharmaceutical fields.
June 2022 Published 20 NFTs with his likeness instead of originally planned DNA NFTs, as part of a project to support genetic research using data from 15,000 individuals.
2021 Published research in Science Translational Medicine on engineered adeno-associated viral vectors that can evade innate immune and inflammatory responses. Co-founded Ally Therapeutics with a postdoc from his lab who was the first author of the research.
2021 Church joined as a co-founder of HLTH.network (formerly Shivom), a healthcare blockchain startup creating the world's first global genomics data sharing and analytics marketplace.
September 13 2021 Church co-founded Colossal Biosciences with entrepreneur Ben Lamm, a company dedicated to using genetic code to revive the woolly mammoth by equipping Asian elephants with mammoth traits.
February 2020 Rejuvenate Bio received an exclusive worldwide license from the Harvard Office of Technology Development to commercialize their gene therapy technology.
February 18 2020 Nebula Genomics, Church's personal genomics company, announced a partnership with BGI to reduce whole-genome sequencing costs, sending saliva samples to BGI labs in Hong Kong for sequencing at a rate of $299 for 30x whole-genome sequencing.
2018 Launched Rejuvenate Bio from the Church lab at the Wyss Institute at Harvard, with the goal of preventing and treating age-related diseases in dogs and extending their overall lifespan.
2018 Church co-founded Nebula Genomics, a personal genomics company offering whole-genome sequencing services with a focus on blockchain technology for privacy and data sharing.
2018 Church's laboratory at Harvard spun off an impressive 16 biotechnology companies in a single year, demonstrating his entrepreneurial impact in the scientific community.
2017 Church lab at Harvard created an adeno-associated virus (AAV)-based single combination gene therapy capable of simultaneously treating multiple age-related diseases in mice, including obesity, type II diabetes, heart failure, and renal failure. This research was published in PNAS.
2017 BGI established the 'George Church Institute of Regenesis', creating a research collaboration between Church's lab and approximately a dozen BGI staffers in China.
2017 Time magazine included Church in the Time 100 list of the most influential people in the world, recognizing his significant contributions to biotechnology and genetics.
March 2015 George Church and his genetics research team at Harvard successfully copied woolly mammoth genes into the genome of an Asian elephant using CRISPR DNA editing technique, splicing genetic segments from frozen mammoth specimens into elephant skin cells.
2012 Church was elected a member of the National Academy of Engineering for his contributions to human genome sequencing technologies and DNA synthesis and assembly.

This contents of the box above is based on material from the Wikipedia article George Church (geneticist), which is released under the Creative Commons Attribution-ShareAlike 4.0 International License.

See Also